DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

ArQule, Inc. (NASDAQ: ARQL)

1.81 -0.07 (-3.47%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARQL $1.81 -3.47%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.89
Previous Close $1.88
Daily Range $1.79 - $1.89
52-Week Range $1.04 - $2.50
Market Cap $113.7M
P/E Ratio -5.68
Dividend (Yield) $0.00 (0.0%)
Volume 182,359
Average Daily Volume 411,839
Current FY EPS -$0.33

Sector

Healthcare

Industry

Drug Makers

ArQule, Inc. (ARQL) Description

A clinical-stage biotechnology company, engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize targeted cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics. Website: http://www.arqule.com/

News & Commentary Rss Feed

ARQL's Top Competitors

ARQL $1.81 (-3.47%)
Current stock: ARQL
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB